Clinical Trials
25 trialsStudy of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial
Alliance for Clinical Trials in Oncology
Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
Alliance for Clinical Trials in Oncology
Hepatobiliary Tumors Tissue Samples Acquisition
Peking Union Medical College Hospital
Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia
Alliance for Clinical Trials in Oncology
TELOGNOSTIC
Hospices Civils de Lyon
MAP
State Scientific Centre of Coloproctology, Russian Federation
Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
National Cancer Institute (NCI)
Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
National Cancer Institute (NCI)
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
National Cancer Institute (NCI)
Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
National Cancer Institute (NCI)
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer
National Cancer Institute (NCI)
Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease
National Cancer Institute (NCI)
Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma
National Cancer Institute (NCI)
Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region
National Cancer Institute (NCI)
Studying Blood Samples in Young Patients With Cytopenia After a Donor Stem Cell Transplant
National Cancer Institute (NCI)
Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
National Cancer Institute (NCI)
GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
National Cancer Institute (NCI)
Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
Cancer Research UK, Glasgow
Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia
University of Glasgow
Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy
National Cancer Institute (NCI)
Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants
National Cancer Institute (NCI)
Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer
National Cancer Institute (NCI)